Skip to Content

WPI 3587 (Armodafinil 250 mg)

Pill with imprint WPI 3587 is White, Capsule-shape and has been identified as Armodafinil 250 mg. It is supplied by Watson Laboratories, Inc..

Armodafinil is used in the treatment of narcolepsy; shift work sleep disorder; obstructive sleep apnea/hypopnea syndrome and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 250 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3587

Armodafinil

Imprint
WPI 3587
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3587

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.